Mouse prostate cancer cell lines established from primary and postcastration recurrent tumors.
about
Inhibition of Hsp90 augments docetaxel therapy in castrate resistant prostate cancerEpithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth.Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis.Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model.Development of a castrate resistant transplant tumor model of prostate cancerOpposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells.AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion.Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination.CAF-secreted annexin A1 induces prostate cancer cells to gain stem cell-like features.Drug discovery in prostate cancer mouse models.Automatic cell cloning assay for determining the clonogenic capacity of cancer and cancer stem-like cells.PI3K, Erk signaling in BMP7-induced epithelial-mesenchymal transition (EMT) of PC-3 prostate cancer cells in 2- and 3-dimensional cultures.Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1.Contextual effect of repression of bone morphogenetic protein activity in prostate cancer.Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells.Multiparameter cytometric analysis of complex cellular response.
P2860
Q28541342-83332194-AF32-4945-ABE6-47CC7827BE5EQ33351622-02548F47-50EC-434D-83B4-80566BC1736AQ33803841-2253C03A-31DE-4642-8B77-9C27AE9C8BD7Q34118737-7BC25B1B-24D8-49B3-8383-7EDAB0842C4DQ35702322-5E4E44AE-594D-418E-BBA3-4E9BA3B74F7CQ35819316-56A6DFD7-F443-493D-84A1-1E6C2CBB84A9Q36546592-C3FCB0E8-4B3B-45EE-8655-559AAAE00C66Q36977833-F2CF412B-8CBC-4F9F-955E-12C37DF6B2F1Q37660683-49B28F6C-13F9-41BD-9C25-705EDB375491Q37707029-8F37937C-93F2-409A-A8F5-FDBCAC1FB829Q38509211-AADB2C39-1822-49C9-97F2-4ED6577736F3Q39186965-5C37BA41-2E5F-406A-B857-9C8ADCDADFCDQ39468018-C646C02A-5F6F-4BC8-927F-42C7C832ECC4Q41520593-E2653C3F-7FA7-4A4C-9CED-E814EA3B8FF9Q41859712-EE1E959C-DFC3-483B-9D82-B94E371B5178Q46140457-6A95C444-7856-45A8-85C3-03A5F9E01E8AQ47268596-93F71D3E-6C07-49CD-9988-FF1B4B31B2C2
P2860
Mouse prostate cancer cell lines established from primary and postcastration recurrent tumors.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mouse prostate cancer cell lin ...... stcastration recurrent tumors.
@ast
Mouse prostate cancer cell lin ...... stcastration recurrent tumors.
@en
type
label
Mouse prostate cancer cell lin ...... stcastration recurrent tumors.
@ast
Mouse prostate cancer cell lin ...... stcastration recurrent tumors.
@en
prefLabel
Mouse prostate cancer cell lin ...... stcastration recurrent tumors.
@ast
Mouse prostate cancer cell lin ...... stcastration recurrent tumors.
@en
P2093
P2860
P4510
P1433
P1476
Mouse prostate cancer cell lin ...... stcastration recurrent tumors.
@en
P2093
Alexander Yu Nikitin
Andrea Flesken-Nikitin
Chun-Peng Liao
Joseph H Jeong
Mengmeng Liang
Michael B Cohen
Pradip Roy-Burman
P2860
P2888
P356
10.1007/S12672-009-0005-Y
P577
2010-02-01T00:00:00Z
P5875
P6179
1051135915